Institute of Health Policy and Management, College of Public Health, National Taiwan University, No. 17, Xu-Zhou Rd., Rm. 639, Zhongzheng Dist., Taipei 10055, Taiwan; Department of Information Systems and Operations Management, College of Business, University of Texas at Arlington, 701 S. West Street, Arlington, Texas 76019, USA.
Institute of Health Policy and Management, College of Public Health, National Taiwan University, No. 17, Xu-Zhou Rd., Rm. 639, Zhongzheng Dist., Taipei 10055, Taiwan.
Health Policy. 2023 Jun;132:104816. doi: 10.1016/j.healthpol.2023.104816. Epub 2023 Apr 5.
The number of treated end stage renal disease (ESRD) patients worldwide has rapidly grown. To prolong their lives ESRD patients require transplantation or dialysis treatment. Limited donor availability has caused most of the ESRD patients to rely on either hemodialysis (HD) or peritoneal dialysis (PD). Taiwan had the highest prevalence rate worldwide and sought to increase the PD utilization through a series of reimbursement incentives. This study evaluated the effect of those policy initiatives. A retrospective longitudinal study using a before-and-after analysis was conducted. ESRD patients initiating either PD or HD were identified from the entire population of Taiwan NHI's beneficiaries. PD patients, before and after the PD-encouraging initiatives, were matched through a propensity score technique, and the change in PD technical failure was analyzed. HD patients were also matched as the control group to assess the impact on PD mortality. The competing risk regression approach for survival analysis was adopted. The results indicate the increase in PD utilization during this period was also accompanied by increases in both technique failure and mortality. Since PD shifts more burden of care to patients, efforts to increase its utilization may require an increase in the education of providers and patients to benefit more effectively. It may also require an increase in staff to provide ongoing training and support as the policy unfolds.
全球范围内接受治疗的终末期肾病(ESRD)患者数量迅速增长。为了延长他们的生命,ESRD 患者需要接受移植或透析治疗。供体的有限可用性导致大多数 ESRD 患者依赖于血液透析(HD)或腹膜透析(PD)。台湾拥有全球最高的患病率,并通过一系列报销激励措施寻求增加 PD 的利用率。本研究评估了这些政策举措的效果。采用前后分析的回顾性纵向研究。从台湾全民健康保险受益人的整个人群中确定开始接受 PD 或 HD 治疗的 ESRD 患者。通过倾向评分技术对 PD 鼓励措施前后的 PD 患者进行匹配,并分析 PD 技术失败的变化。HD 患者也被匹配为对照组,以评估对 PD 死亡率的影响。采用生存分析的竞争风险回归方法。结果表明,在此期间 PD 利用率的增加也伴随着技术失败和死亡率的增加。由于 PD 将更多的护理负担转移给患者,因此增加 PD 的利用率可能需要增加提供者和患者的教育,以更有效地受益。随着政策的实施,这可能还需要增加员工来提供持续的培训和支持。